Ventyx Biosciences, Inc. - VTYX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 05, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Feb 19, 2026 | SCHEDULE 13G | Glazer Capital, LLC | 6.23% | 4,446,004 | View |
| Feb 19, 2026 | SCHEDULE 13G | Paul J. Glazer | 6.23% | 4,446,004 | View |
| Feb 05, 2026 | SCHEDULE 13G | Morgan Stanley | 6.0% | 4,289,915 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | Affinity Asset Advisors, LLC | 9.0% | 6,465,041 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | Michael Cho | 9.0% | 6,465,041 | View |
| Jan 09, 2026 | SCHEDULE 13D/A | — | — | 1,807,664 | View |
| Jan 09, 2026 | SCHEDULE 13D/A | — | — | 71,358,638 | View |
| Nov 26, 2025 | SCHEDULE 13D | — | 6.0% | 71,358,638 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 4.5% | 3,209,645 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 4.5% | 3,209,645 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Steven A. Cohen | 4.5% | 3,209,645 | View |
| Oct 31, 2025 | SCHEDULE 13G | The Vanguard Group | 5.28% | 3,769,997 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.